Suppression of 5-lipoxygenase gene is involved in triptolide-induced apoptosis in pancreatic tumor cell lines

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 7, 2007, Pages 1021-1027

  Zhou, G X ^a   Ding, X L ^a   Huang, J F ^a   Zhang, H ^a   Wu, S B ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

5 lipoxygenase; Bcl 2; Caspase 3; Pancreatic tumor; Triptolide

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; LEUKOTRIENE B4; PROTEIN BCL 2; TRIPTOLIDE;

APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPOXY COMPOUNDS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IN SITU NICK-END LABELING; LEUKOTRIENE B4; LUCIFERASES; PANCREAS; PHENANTHRENES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34247605460     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.03.002     Document Type: Article

References (28)

1. Howard T.J. Pancreatic adenocarcinoma. Curr. Probl. Cancer 20 (1996) 281-328
2. Parker S.L., Tong T., Bolden S., and Wingo P.A. Cancer statistics, 1996 CA Cancer. J. Clin. 46 (1996) 5-27
3. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., and Thun M.J. Cancer statistics, 2003 CA Cancer. J. Clin. 53 (2003) 5-26
4. Qin W.Z., Zhu G.D., Yang S.M., Han K.Y., and Wang J. Clinical observations on Tripterygium wilfordii in treatment of 26 cases of discoid lupus erythematosus. J. Tradit. Chin. Med. 3 (1983) 131-132
5. Tao X.L., Sun Y., Dong Y., Xiao Y.L., Hu D.W., Shi Y.P., Zhu Q.L., Dai H., and Zhang N.Z. A prospective, controlled, double-blind, cross-over study of Tripterygium wilfordii hook F in treatment of rheumatoid arthritis. Chin. Med. J. (Engl.) 102 (1989) 327-332
6. Chen B.J. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk. Lymphoma 42 (2001) 253-265
7. Shamon L.A., Pezzuto J.M., Graves J.M., Mehta R.R., Wangcharoentrakul S., Sangsuwan R., Chaichana S., Tuchinda P., Cleason P., and Reutrakul V. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett. 112 (1997) 113-117
8. Wei Y.S., and Adachi I. Inhibitory effect of triptolide on colony formation of breast and stomach cancer cell lines. Zhongguo Yao Li Xue. Bao. 12 (1991) 406-410
9. Yang S., Chen J., Guo Z., Xu X.M., Wang L., Pei X.F., Yang J., Underhill C.B., and Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2 (2003) 65-72
10. Kiviharju T.M., Lecane P.S., Sellers R.G., and Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer Res. 8 (2002) 2666-2674
11. Yang Y., Liu Z., Tolosa E., Yang J., and Li L. Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 40 (1998) 139-149
12. Lee K.Y., Chang W., Qiu D., Kao P.N., and Rosen G.D. PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J. Biol. Chem. 274 (1999) 13451-13455
13. Lee K.Y., Park J.S., Jee Y.K., and Rosen G.D. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Exp. Mol. Med. 34 (2002) 462-468
14. Chang W.T., Kang J.J., Lee K.Y., Wei K., Anderson E., Gotmare S., Ross J.A., and Rosen G.D. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J. Biol. Chem. 276 (2001) 2221-2227
15. Jiang X.H., Wong B.C., Lin M.C., Zhu G.H., Kung H.F., Jiang S.H., Yang D., and Lam S.K. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 20 (2001) 8009-8018
16. Chan E.W., Cheng S.C., Sin F.W., and Xie Y. Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines. Toxicol. Lett. 122 (2001) 81-87
17. Carter B.Z., Mak D.H., Schober W.D., McQueen T., Harris D., Estrov Z., Evans R.L., and Andreeff M. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood 108 (2006) 630-637
18. Shureiqi I., and Lippman S.M. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 61 (2001) 6307-6312
19. Dixon R.A., Diehl R.E., Opas E., Rands E., Vickers P.J., Evans J.F., Gillard J.W., and Miller D.K. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343 (1990) 282-284
20. Hennig R., Ding X.Z., Tong W.G., Schneider M.B., Standop J., Friess H., Buchler M.W., Pour P.M., and Adrian T.E. 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am. J. Pathol. 161 (2002) 421-428
21. Ding X.Z., Iversen P., Cluck M.W., Knezetic J.A., and Adrian T.E. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 261 (1999) 218-223
22. Liu Q., Chen T., Chen H., Zhang M., Li N., Lu Z., Ma P., and Cao X. Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation. Biochem. Biophys. Res. Commun. 319 (2004) 980-986
23. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25 (2001) 402-408
24. Leuenroth S.J., and Crews C.M. Studies on calcium dependence reveal multiple modes of action for triptolide. Chem. Biol. 12 (2005) 1259-1268
25. Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., Ng J.C., and Kao P.N. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J. Biol. Chem. 274 (1999) 13443-13450
26. Silverman E.S., Le L., Baron R.M., Hallock A., Hjoberg J., Shikanai T., Storm van's G.K., Auron P.E., and Lu W. Cloning and functional analysis of the mouse 5-lipoxygenase promoter. Am. J. Respir. Cell Mol. Biol. 26 (2002) 475-483
27. Jozefowski S., Biedron R., Bobek M., and Marcinkiewicz J. Leukotrienes modulate cytokine release from dendritic cells. Immunology 116 (2005) 418-428
28. Choi Y.J., Kim T.G., Kim Y.H., Lee S.H., Kwon Y.K., Suh S.I., Park J.W., and Kwon T.K. Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cells. Biochem. Pharmacol. 66 (2003) 273-280